Skip to main navigation Skip to search Skip to main content

ACNS1833-A phase 3 randomized non inferiority study of carboplatin and vincristine vs selumetinib in newly diagnosed or previously untreated low grade glioma not associated with BRAFV600E mutations or systemic neurofribromatotis type 1

Project: Research

Project Details

StatusActive
Effective start/end date07/1/22 → 06/30/27

Funding

  • National Cancer Institute: $1.00